RSS   Newsletter   Contact   Advertise with us
Post Online Media

Oxford BioTherapeutics appoints two biotech veterans

Oxford BioTherapeuticsOxford BioTherapeutics, a biotechnology company, announced the appointment of Bernd Seizinger as xhairman and Jean-Pierre Bizzari as a non-executive director.
Article continues below

READ MORE Oxford BioTherapeutics appoints chairman

Mr. Seizinger brings over 20 years of industry experience, from a number of senior executive board positions in pharma and biotech companies on both sides of the Atlantic.

These include Bristol-Myers Squibb (VP oncology drug discovery and VP Corporate and Academic alliances), GPC Biotech (CEO and President), and Chairman of Aprea, Opsona and CryptoMedix.

Mr. Bizzari brings 32 years' experience including as EVP and Group Head of Clinical Oncology at Celgene until 2015, and Sanofi Aventis prior to that, and has directed the clinical development and approval of a number of important anti-cancer medicines.

 LATEST MOVES FROM United Kingdom 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy